Weigang Wu
-
- MicroRNA in disease regulation 2
-
- Traditional Chinese Medicine Analysis 3
-
- Phytochemicals and Antioxidant Activities 3
-
- Natural product bioactivities and synthesis 3
- Genomics, phytochemicals, and oxidative stress 2
- RNA Interference and Gene Delivery 2
-
- Shoulder Injury and Treatment 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Boping ZhouXiaobin ZengHaoqiang WanBin LiJiemei LiLanlan GeDazhi YangYuan Liu
- Journals
- Advanced Materials (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Weigang Wu
32 papers receiving 471 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 69
- Complementary and alternative medicine 37
- Toxicology 15
- Biochemistry 21
- Molecular Biology 227
Countries citing papers authored by Weigang Wu
This map shows the geographic impact of Weigang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Wu more than expected).
Fields of papers citing papers by Weigang Wu
This network shows the impact of papers produced by Weigang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Wu. The network helps show where Weigang Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weigang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 39 | |
| 5 | 2022 | 9 | |
| 6 | 2021 | 33 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 26 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 18 | |
| 12 | 2019 | 0 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 27 | |
| 17 | 2018 | 5 | |
| 18 | 2017 | 15 | |
| 19 | 2016 | 25 | |
| 20 | 2014 | 4 |
About Weigang Wu
Weigang Wu is a scholar working on Complementary and alternative medicine, Biochemistry and Pharmacology, having authored 34 papers that have together received 481 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (3 papers), Natural product bioactivities and synthesis (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Shoulder Injury and Treatment (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (69 citations), Complementary and alternative medicine (37 citations) and Toxicology (15 citations). Weigang Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Boping Zhou, Xiaobin Zeng, Haoqiang Wan, Bin Li, Jiemei Li, Lanlan Ge, Dazhi Yang, Yuan Liu, Shan He and Shusong Peng. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.